Case | Sex | age (year) | Primary site | Initial diagnosis | A A | Size (cm) | Oberlin Score | Total | Bone | PAX/ FOXO | Pathol- ogical | Immunohistochemically |
---|---|---|---|---|---|---|---|---|---|---|---|---|
metastasis | metastasis | |||||||||||
1 | M | 11.8 | Groin | NHL | N | 9 | 4 | 7 | P | N | ERMS | Desmin(+),Vimentin(+), MyoD1(+), Myogenin(+) |
2 | M | 3.2 | Chest wall | PPB | N | 5 | 4 | 8 | P | – | ERMS | Desmin(+), MyoD1(+), Myogenin(+) |
3 | F | 2.9 | chest wall | AL | Y | 7.7 | 4 | 7 | P | P | ARMS | Desmin(+),Myogenin(+), Vimentin(+), |
4 | M | 2 | Pelvic cavity | AML | Y | 4 | 4 | 7 | N | – | ARMS | Desmin(+), Myoglobin(+) |
5 | M | 1.7 | Lower jaw | AML | N | 3.7 | 4 | 17 | P | P | ARMS | Desmin(+),Vimentin (+), Myogenin(+) |
6 | M | 5.8 | cranial base | PPB | Y | 6.6 | 4 | 4 | P | N | ERMS | Desmin(+), MyoD1(+),Myogenin(+) |
7 | M | 12 | Nasopharynx | RMS | N | 4.5 | 4 | 10 | P | P | ARMS | Desmin(+), MyoD1(+), Myogenin(+) |
8 | M | 8.4 | Palm | NB | Y | 3.1 | 4 | 9 | P | P | ARMS | Desmin(+), MyoD2(+), Myogenin(+) |
9 | M | 5.6 | Bladder | RMS | N | 7 | 4 | 4 | P | N | ERMS | Desmin(+), MyoD1(+),Myogenin(+) |
10 | F | 13 | Mediastinum | PPB | Y | 8.4 | 4 | 3 | N | P | ARMS | Desmin(+), Vimentin(+), Myogenin(+) |
11 | F | 14 | Sole | RMS | N | 2.4 | 4 | 4 | P | P | ARMS | Desmin (+), Vimentin(+), MyoD1(+), Myogenin(+) |
12 | M | 5.4 | Pelvic cavity | HL | N | 10 | 4 | 9 | P | P | ARMS | Desmin(+), MyoD1(+), Myogenin(+) |
13 | M | 2.1 | Pelvic cavity | RMS | N | 12.9 | 4 | 6 | P | P | ARMS | Desmin(+), MyoD1(+),Myogenin(+) |